NASH
- Business
Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
Copenhagen, Denmark & Ingelheim, Germany: New studies mark an important advancement of Boehringer Ingelheim’s cardiometabolic focus areas obesity and NASH.…
Read More » - World
LG Chem Life Sciences and TransThera Biosciences Announce FDA Clearance of IND for TT-01025, a SSAO/VAP-1 Inhibitor
Nanjing, China & Seoul, Korea: LG Chem Life Sciences (“LG Chem”), a division of LG Chem, and TransThera Biosciences Co.…
Read More » - United States
Terns Pharmaceuticals to Present Data on Multiple NASH Programs at The Digital International Liver Congress™ 2020
Foster City, Calif., United States: -Single doses of TERN-201 were safe and well tolerated and demonstrated potent, selective, and sustained…
Read More » - United States
LG Chem Life Sciences and TransThera Biosciences Announce License Agreement for Potential Treatment of NASH and Other Chronic Inflammatory Conditions
Nanjing, China & Seoul, South Korea: LG Chem Life Sciences (“LG Chem”), a division of LG Chem, and TransThera Biosciences…
Read More »